KeyBanc upgrades Plexus stock rating on growth prospects

KeyBanc upgraded Plexus to Overweight from Sector Weight with a $300 price target, implying upside from the $252.36 share price despite concerns that the stock is above InvestingPro's Fair Value estimate. Plexus reported fiscal Q3 non-GAAP EPS of $2.32 versus $2.13 consensus and record revenue of $1.3 billion versus $1.23 billion expected, with revenue rising 28% year over year. The company raised its growth outlook through fiscal 2027, although continued reinvestment may modestly constrain near-term margin expansion.

Analysis

PLXS’s rerating now depends less on revenue momentum and more on proof that its regulated-market mix can support durable operating leverage despite ongoing capacity and program investments. In a contract-manufacturing model, incremental growth can consume working capital and capex before it converts to free cash flow; the key earnings-risk is therefore a widening gap between adjusted EPS and cash conversion over the next 2-3 quarters. FLEX, SANM, and Jabil (JBL) are the relevant valuation checks: if PLXS cannot demonstrate superior returns on invested capital and mix-driven margins, its premium multiple is vulnerable even if sales remain strong.

The consensus risk is treating upward estimate revisions as a clean extrapolation signal after a substantial share-price advance. With limited gross-margin buffer, adverse customer/program mix, component availability normalization, or pricing resets can disproportionately pressure earnings; regulated end markets reduce cyclicality but do not eliminate project timing risk. A bullish structural case requires fiscal-2027 guidance to translate into rising free-cash-flow conversion rather than simply higher revenue and investment intensity.

Near term, the next earnings release and updated backlog/book-to-bill commentary are the principal catalysts; a guidance raise paired with stable or improving cash conversion can justify further multiple expansion over 1-3 months. Conversely, a reduction in margin outlook, inventory build, or weaker-than-expected operating cash flow would likely matter more than another modest revenue beat. The article’s unrelated BABA reference provides no actionable read-through for PLXS.

Key Decisions for Investors

• Do not chase PLXS at current levels; initiate only on a post-results pullback or after confirmation that operating cash flow keeps pace with earnings. Upside to the stated $300 target is roughly 19%, which is insufficient compensation without evidence of improving cash conversion.
• Use a conditional long PLXS position over the next 1-3 months if management maintains or raises fiscal-2027 outlook while delivering stable-to-higher gross margin and no material working-capital deterioration. Falsify the thesis on a guidance cut, gross-margin compression, or a meaningful inventory/receivables-led cash-flow miss.
• For a relative-value expression, monitor long PLXS/short FLEX only if PLXS demonstrates sustained margin or return-on-capital outperformance at the next report; absent that evidence, the premium-quality narrative is not sufficiently differentiated to support the pair.
• Track SANM and JBL earnings for program-demand and pricing commentary. Broad electronics-manufacturing weakness would indicate that PLXS’s apparent resilience is company-specific and potentially less durable than current estimates imply.